Rypka KJ, Goldfarb N, Mansh M. Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors". J Am Acad Dermatol 2023 Jun 26:S0190-9622(23)01188.
PMID: 37379901